Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc, 11329-11330 [2021-03760]
Download as PDF
<![CDATA[
11329
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–794 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
DATES:
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on January 25, 2021, GGGYI LLC, 4168
South Drexel Boulevard 2A, Chicago,
Illinois 60653, applied to be registered
as a bulk manufacturer of the following
basic class(es) of controlled substances:
Controlled
substance
Drug
code
Marihuana Extract ...................
Marihuana ...............................
Tetrahydrocannabinols ...........
7350
7360
7370
Schedule
I
I
I
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03754 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–770]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Research
Biochemicals, Inc, has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 17, 2020,
Sigma Aldrich Research Biochemicals,
Inc, 400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
4-Methyl-N-Methylcathinone ............................................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH-018 & AM678 ..........................................................................................................................................................
Lysergic Acid Diethylamide .............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Alpha-Methyltryptamine ...................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
5-Methoxy-N,N-Diisopropyltryptamine .............................................................................................................................
1-Benzylpiperazine ..........................................................................................................................................................
2-(2,5-Dimethoxyphenyl) Ethanamine .............................................................................................................................
3,4-Methylenedioxypyrovalerone .....................................................................................................................................
3,4-Methylenedioxy-N-Methylcathinone ..........................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
1235
1248
2565
7118
7315
7370
7381
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
1100
1724
7379
7471
9041
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
11330
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
Controlled substance
Drug code
Codeine ...........................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-Alphacetylmethadol (LAAM) ...................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
reference standards.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03760 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–796]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Livwell
Michigan, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–796 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on January 25, 2021, Livwell Michigan,
LLC, 21550 Hoover Road, Warren,
Michigan 48089, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
Controlled
substance
Marihuana Extract ...................
Marihuana ...............................
Tetrahydrocannabinols ...........
9050
9180
9220
9230
9250
9300
9333
9648
9668
9739
9740
9743
9801
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug
code
7350
7360
7370
Schedule
I
I
I
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03759 Filed 2–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–792]
Bulk Manufacturer of Controlled
Substances Application: Synthcon
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Synthcon LLC, has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on January 5, 2021,
Synthcon LLC., 770 Wooten Road, Suite
101, Colorado Springs, Colorado 80915–
3538, applied to be registered as a bulk
SUMMARY:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11329-11330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03760]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-770]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sigma Aldrich Research Biochemicals, Inc, has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 26, 2021.
Such persons may also file a written request for a hearing on the
application on or before April 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on December 17, 2020, Sigma Aldrich Research
Biochemicals, Inc, 400-600 Summit Drive, Burlington, Massachusetts
01803, applied to be registered as a bulk manufacturer of the following
basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone.......................... 1235 I
4-Methyl-N-Methylcathinone......... 1248 I
Methaqualone....................... 2565 I
JWH-018 & AM678.................... 7118 I
Lysergic Acid Diethylamide......... 7315 I
Tetrahydrocannabinols.............. 7370 I
Mescaline.......................... 7381 I
3,4-Methylenedioxymethamphetamine.. 7405 I
Alpha-Methyltryptamine............. 7432 I
Dimethyltryptamine................. 7435 I
5-Methoxy-N,N-Diisopropyltryptamine 7439 I
1-Benzylpiperazine................. 7493 I
2-(2,5-Dimethoxyphenyl) Ethanamine. 7517 I
3,4-Methylenedioxypyrovalerone..... 7535 I
3,4-Methylenedioxy-N- 7540 I
Methylcathinone.
Heroin............................. 9200 I
Normorphine........................ 9313 I
Norlevorphanol..................... 9634 I
Amphetamine........................ 1100 II
Methylphenidate.................... 1724 II
Nabilone........................... 7379 II
Phencyclidine...................... 7471 II
Cocaine............................ 9041 II
[[Page 11330]]
Codeine............................ 9050 II
Ecgonine........................... 9180 II
Levorphanol........................ 9220 II
Meperidine......................... 9230 II
Methadone.......................... 9250 II
Morphine........................... 9300 II
Thebaine........................... 9333 II
Levo-Alphacetylmethadol (LAAM)..... 9648 II
Noroxymorphone..................... 9668 II
Remifentanil....................... 9739 II
Sufentanil......................... 9740 II
Carfentanil........................ 9743 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03760 Filed 2-23-21; 8:45 am]
BILLING CODE 4410-09-P
